Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Resistance and Heart Disease
2009-017176-25Phase 3Unknown
- Sponsor
- Sandwell and West Birmingham NHS Trust
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of aspirin in coronary arteriosclerosis and Atrial fibrillation (AFib) (2 arms), sponsored by Sandwell and West Birmingham NHS Trust. Primary endpoints: Frequency of aspirin resistance in coronary artery disease and atrial fibrillation, Relationship of aspirin resistance with vascular function and 2 more. Status: unknown.
02
Drugs
aspirin
03
Conditions
coronary arteriosclerosisAtrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-017176-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017176-25.